GHO Capital Partners related stories
All articles and analysis
Evercore terminates fundraising relationship with France’s KeensightThe investment bank has said it will no longer work with the tech and healthcare investor on placing its latest flagship fund, which is expected to seek at least €3bn.
PE taps into CDMO market’s ‘strong growth’: 7 deals65 Equity Partners, Arlington Capital Partners and Vance Street Capital are among the PE firms targeting investments in the CDMO market.
Treatments for neurological disorders draw PE interest: 5 dealsArchimed, EQT and Partners Group are among the PE firms investing in neurology-focused companies.
GHO Capital, Ampersand Capital to buy Avid Bioservices in $1.1bn dealAvid Bioservices is a biologics CDMO based in California.
Partners Group embraces AI to drive growth in FairJourney BiologicsThe firm agreed to buy a majority stake in FairJourney, valued at around €900m, in early July.
Partners Group goes for majority stake in FairJourney BiologicsFairJourney is an antibody discovery contract research organisation.
GHO Capital appoints Stuart Quin as partnerQuin most recently served as chief executive officer at Medica Group.
Healthcare front of mind for secondaries buyersHealthcare-related assets make up a significant chunk of potential dealflow in the GP-led secondaries market given the sector’s characteristics and outlook.
Partners Group plans to ride pharma reshoring wave'Brexit is really coming into force' as a driver for reshoring, says Partners Group's Pascal Noth.
- GHO Capital, Partners Group invest in Sterling Pharma Solutions
Sterling Pharma Solutions is a global contract development and manufacturing organisation.